Join EVERSANA at the BioCentury-BayHelix China Healthcare Summit
Shanghai | November 2-4, 2026
China’s biotech innovators are reshaping the global market, but many companies still face the same choice: out-license valuable assets or build global infrastructure independently. At BioCentury China, EVERSANA will explore a third path that helps companies retain more value, reduce risk, and accelerate global commercialization.
Featured Session
Your Innovation. Your Upside. Why Give It Away?
你的创新，你的未来价值 – 为什么要让给别人？
A Third Path to Global Commercialization
全球商业化的第三条途径
Traditional commercialization models often require companies to choose between immediate revenue through licensing or significant investment to launch independently. This session will explore an alternative approach that can help companies:
- Retain greater ownership and future value
- Reduce commercialization risk
- Access global expertise and infrastructure
- Accelerate entry into new markets
Speakers
| Dan Feldman Senior Vice President Strategy & Development, UK, EU & APAC |
Andrew Ying Director Strategy & Development, APAC |
Meet with EVERSANA
Whether you’re evaluating licensing opportunities, preparing for an international launch, or exploring new commercialization models, EVERSANA can help across:
- Global commercialization strategy
- Market access and pricing
- Launch planning and execution
- Commercial infrastructure and field deployment
- Integrated commercialization partnerships
Schedule a Meeting
Planning for global growth? Connect with EVERSANA during the conference to discuss global expansion, launch readiness, market access, and alternatives to out-licensing.
SCHEDULE A STRATEGY SESSION